2008
DOI: 10.1038/ncprheum0700
|View full text |Cite
|
Sign up to set email alerts
|

Tendinopathy—from basic science to treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

9
379
1
26

Year Published

2013
2013
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 403 publications
(415 citation statements)
references
References 68 publications
9
379
1
26
Order By: Relevance
“…MMPs 1 and 13 were selected as they are known to be active against fibrillar collagens, including the predominant collagen type I 1, 28, 29, 30. MMP‐3 was selected as it degrades other minor proteins in tendon matrix, including collagens III, IV, IX, and X, and also proteoglycans and elastin 28, 29, 30, 31, 32, 33.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…MMPs 1 and 13 were selected as they are known to be active against fibrillar collagens, including the predominant collagen type I 1, 28, 29, 30. MMP‐3 was selected as it degrades other minor proteins in tendon matrix, including collagens III, IV, IX, and X, and also proteoglycans and elastin 28, 29, 30, 31, 32, 33.…”
Section: Methodsmentioning
confidence: 99%
“…Tendinopathy is a general term for chronic tendon disease1 characterized by a combination of pain, swelling, and impaired tendon performance 2. The aetiology of this disease remains to be elucidated and is likely to be multi‐factorial.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Despite its prevalence and debilitating nature, the basis for the age-associated increase in tendinopathy is unknown, although tendon injuries are thought to be preceded by changes in the underlying structure and mechanical properties (Riley 2008). We have shown that tendons stiffen considerably with age (Wood et al 2011), but the associated changes in underlying structure have not been fully elucidated.…”
Section: Introductionmentioning
confidence: 94%